{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:51:59Z","timestamp":1740163919882,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"crossref","award":["DMR-109-189"],"award-info":[{"award-number":["DMR-109-189"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To investigate the impact of chronic hepatitis on cardiovascular events in patients with type 2 diabetes mellitus (T2DM). This nationwide retrospective cohort study included 152,709 adult patients (&gt;\u200920\u00a0years) with T2DM enrolled in the National Health Insurance Diabetes Pay-for-Performance Program from 2008 to 2010 and followed up until the end of 2017. Patients were categorized into groups with hepatitis B, hepatitis C, fatty liver disease, and patients without chronic hepatitis. The incidence of cardiovascular events in patients with T2DM and hepatitis C (79.9\/1000 person-years) was higher than that in patients with diabetes combined with other chronic hepatitis, or without chronic hepatitis. After adjusting for confounding factors, T2DM with fatty liver (adjusted hazard ratio [HR]: 1.10; 95% confidence interval [CI]: 1.07\u20131.13) and hepatitis C (adjusted HR: 1.09; 95% CI: 1.03\u20131.12) demonstrated a significantly higher risk of cardiovascular events. The adjusted visit-to-visit coefficient of variation of HbA1c and fasting blood glucose were associated with a high risk of cardiovascular events (HRs of the highest quartile were 1.05 and 1.12, respectively). Chronic hepatitis affects cardiovascular events in adult patients with T2DM. Glucose variability could be an independent risk factor for cardiovascular events in such patients.<\/jats:p>","DOI":"10.1038\/s41598-022-15827-x","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T11:02:54Z","timestamp":1657364574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of chronic hepatitis on cardiovascular events among type 2 diabetes patients in Taiwan pay-for-performance program"],"prefix":"10.1038","volume":"12","author":[{"given":"Yi-Jing","family":"Sheen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Tseng","family":"Kung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ting","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,9]]},"reference":[{"key":"15827_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.amjmed.2007.03.025","volume":"120","author":"IJ Hickman","year":"2007","unstructured":"Hickman, I. J. & Macdonald, G. A. Impact of diabetes on the severity of liver disease. Am. J. Med. 120, 829\u2013834. https:\/\/doi.org\/10.1016\/j.amjmed.2007.03.025 (2007).","journal-title":"Am. J. Med."},{"key":"15827_CR2","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1136\/jech-2015-205518","volume":"69","author":"L Xu","year":"2015","unstructured":"Xu, L. et al. Liver enzymes and incident diabetes in China: A prospective analysis of 10 764 participants in the Guangzhou Biobank Cohort Study. J. Epidemiol. Community Health 69, 1040\u20131044. https:\/\/doi.org\/10.1136\/jech-2015-205518 (2015).","journal-title":"J. Epidemiol. Community Health"},{"key":"15827_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3748\/wjg.15.280","volume":"15","author":"D Garcia-Compean","year":"2009","unstructured":"Garcia-Compean, D., Jaquez-Quintana, J. O., Gonzalez-Gonzalez, J. A. & Maldonado-Garza, H. Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management. World J. Gastroenterol. 15, 280\u2013288. https:\/\/doi.org\/10.3748\/wjg.15.280 (2009).","journal-title":"World J. Gastroenterol."},{"key":"15827_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/mpa.0b013e31811f44fd","volume":"35","author":"JY Hsiao","year":"2007","unstructured":"Hsiao, J. Y. et al. Decreased insulin secretion and insulin sensitivity are associated with liver function in subjects with fasting glucose between 100 and 109 mg\/dl in Taiwanese population. Pancreas 35, 343\u2013347. https:\/\/doi.org\/10.1097\/mpa.0b013e31811f44fd (2007).","journal-title":"Pancreas"},{"key":"15827_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.metabol.2009.07.038","volume":"59","author":"YY Wang","year":"2010","unstructured":"Wang, Y. Y., Lin, S. Y., Sheu, W. H., Liu, P. H. & Tung, K. C. Obesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection. Metabolism 59, 486\u2013491. https:\/\/doi.org\/10.1016\/j.metabol.2009.07.038 (2010).","journal-title":"Metabolism"},{"key":"15827_CR6","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1111\/j.1572-0241.2008.01996.x","volume":"103","author":"JF Huang","year":"2008","unstructured":"Huang, J. F. et al. Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection. Am. J. Gastroenterol. 103, 1933\u20131940. https:\/\/doi.org\/10.1111\/j.1572-0241.2008.01996.x (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"15827_CR7","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/j.1572-0241.2007.01181.x","volume":"102","author":"JF Huang","year":"2007","unstructured":"Huang, J. F. et al. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: An epidemiological link with virological implication. Am. J. Gastroenterol. 102, 1237\u20131243. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01181.x (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"15827_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.beem.2016.06.006","volume":"30","author":"S Lallukka","year":"2016","unstructured":"Lallukka, S. & Yki-J\u00e4rvinen, H. Non-alcoholic fatty liver disease and risk of type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 30, 385\u2013395. https:\/\/doi.org\/10.1016\/j.beem.2016.06.006 (2016).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"15827_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3978\/j.issn.2304-3881.2015.01.03","volume":"4","author":"HB Bhatt","year":"2015","unstructured":"Bhatt, H. B. & Smith, R. J. Fatty liver disease in diabetes mellitus. Hepatobiliary Surg. Nutr. 4, 101\u2013108. https:\/\/doi.org\/10.3978\/j.issn.2304-3881.2015.01.03 (2015).","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"15827_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0929-6646(09)60231-X","volume":"106","author":"CH Chen","year":"2007","unstructured":"Chen, C. H. et al. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J. Formos. Med. Assoc. 106, 148\u2013155. https:\/\/doi.org\/10.1016\/S0929-6646(09)60231-X (2007).","journal-title":"J. Formos. Med. Assoc."},{"key":"15827_CR11","first-page":"309","volume":"57","author":"V Goral","year":"2010","unstructured":"Goral, V., Atalay, R. & Kucukoner, M. Insulin resistance in liver cirrhosis. Hepatogastroenterology 57, 309\u2013315 (2010).","journal-title":"Hepatogastroenterology"},{"key":"15827_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejim.2014.12.001","volume":"26","author":"R Pais","year":"2015","unstructured":"Pais, R. et al. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease. Eur. J. Intern. Med. 26, 30\u201336. https:\/\/doi.org\/10.1016\/j.ejim.2014.12.001 (2015).","journal-title":"Eur. J. Intern. Med."},{"key":"15827_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000535","volume":"7","author":"MM Rahman","year":"2020","unstructured":"Rahman, M. M. et al. Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia. BMJ Open Gastroenterol. 7, e000535. https:\/\/doi.org\/10.1136\/bmjgast-2020-000535 (2020).","journal-title":"BMJ Open Gastroenterol."},{"key":"15827_CR14","doi-asserted-by":"publisher","first-page":"9674","DOI":"10.3748\/wjg.v22.i44.9674","volume":"22","author":"A Lonardo","year":"2016","unstructured":"Lonardo, A. et al. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease\u2014Evidence from three different disease models: NAFLD, HCV and HIV. World J. Gastroenterol. 22, 9674\u20139793. https:\/\/doi.org\/10.3748\/wjg.v22.i44.9674 (2016).","journal-title":"World J. Gastroenterol."},{"key":"15827_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrneph.2016.181","volume":"13","author":"PK Li","year":"2017","unstructured":"Li, P. K. et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat. Rev. Nephrol. 13, 90\u2013103. https:\/\/doi.org\/10.1038\/nrneph.2016.181 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"15827_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2337\/dc17-1590","volume":"41","author":"SH Wild","year":"2018","unstructured":"Wild, S. H. et al. Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission. Diabetes Care 41, 341\u2013347. https:\/\/doi.org\/10.2337\/dc17-1590 (2018).","journal-title":"Diabetes Care"},{"key":"15827_CR17","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne, C. D. & Targher, G. NAFLD: A multisystem disease. J. Hepatol. 62, S47-64. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012 (2015).","journal-title":"J. Hepatol."},{"key":"15827_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s40618-017-0799-3","volume":"41","author":"MG Radaelli","year":"2018","unstructured":"Radaelli, M. G. et al. NAFLD\/NASH in patients with type 2 diabetes and related treatment options. J. Endocrinol. Investig. 41, 509\u2013521. https:\/\/doi.org\/10.1007\/s40618-017-0799-3 (2018).","journal-title":"J. Endocrinol. Investig."},{"key":"15827_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/CRD.0000000000000031","volume":"23","author":"V Katsi","year":"2015","unstructured":"Katsi, V. et al. Cardiovascular disease and hepatitis C virus infection: An irrelevant statement or a hot relationship?. Cardiol. Rev. 23, 11\u201317. https:\/\/doi.org\/10.1097\/CRD.0000000000000031 (2015).","journal-title":"Cardiol. Rev."},{"key":"15827_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cld.2017.03.003","volume":"21","author":"N Goossens","year":"2017","unstructured":"Goossens, N. & Negro, F. Cardiovascular manifestations of hepatitis C virus. Clin. Liver Dis. 21, 465\u2013473. https:\/\/doi.org\/10.1016\/j.cld.2017.03.003 (2017).","journal-title":"Clin. Liver Dis."},{"key":"15827_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.21037\/atm.2016.11.12","volume":"4","author":"K Wijarnpreecha","year":"2016","unstructured":"Wijarnpreecha, K., Thongprayoon, C., Panjawatanan, P. & Ungprasert, P. Hepatitis B virus infection and risk of coronary artery disease: A meta-analysis. Ann. Transl. Med. 4, 423. https:\/\/doi.org\/10.21037\/atm.2016.11.12 (2016).","journal-title":"Ann. Transl. Med."},{"key":"15827_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004197","volume":"95","author":"YC Chen","year":"2016","unstructured":"Chen, Y. C., Lee, C. T., Lin, B. J., Chang, Y. Y. & Shi, H. Y. Impact of pay-for-performance on mortality in diabetes patients in Taiwan: A population-based study. Medicine 95, e4197. https:\/\/doi.org\/10.1097\/MD.0000000000004197 (2016).","journal-title":"Medicine"},{"key":"15827_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1046\/j.1440-1746.2002.02755.x","volume":"17","author":"A Holstein","year":"2002","unstructured":"Holstein, A., Hinze, S., Thiessen, E., Plaschke, A. & Egberts, E. H. Clinical implications of hepatogenous diabetes in liver cirrhosis. J. Gastroenterol. Hepatol. 17, 677\u2013681. https:\/\/doi.org\/10.1046\/j.1440-1746.2002.02755.x (2002).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"15827_CR24","unstructured":"Data from Ministry of Health and Welfare: 2017 report on the implementation results of hospitals and other budget projects. https:\/\/dep.mohw.gov.tw\/nhic\/cp-1664-36968-116.html [Accessed October 11, 2021]."},{"key":"15827_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"15827_CR26","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.tem.2019.08.008","volume":"30","author":"D Stols-Gon\u00e7alves","year":"2019","unstructured":"Stols-Gon\u00e7alves, D., Hovingh, G. K., Nieuwdorp, M. & Holleboom, A. G. NAFLD and atherosclerosis: Two sides of the same dysmetabolic coin?. Trends Endocrinol. Metab. 30, 891\u2013902. https:\/\/doi.org\/10.1016\/j.tem.2019.08.008 (2019).","journal-title":"Trends Endocrinol. Metab."},{"key":"15827_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6150861","volume":"2018","author":"S Drazilova","year":"2018","unstructured":"Drazilova, S., Gazda, J., Janicko, M. & Jarcuska, P. Chronic hepatitis C association with diabetes mellitus and cardiovascular risk in the era of DAA therapy. Can. J. Gastroenterol. Hepatol. 2018, 6150861. https:\/\/doi.org\/10.1155\/2018\/6150861 (2018).","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"15827_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jhep.2018.02.015","volume":"69","author":"S Petta","year":"2018","unstructured":"Petta, S. et al. Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis. J. Hepatol. 69, 18\u201324. https:\/\/doi.org\/10.1016\/j.jhep.2018.02.015 (2018).","journal-title":"J. Hepatol."},{"key":"15827_CR29","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2169\/internalmedicine.1514-18","volume":"58","author":"T Ichikawa","year":"2019","unstructured":"Ichikawa, T. et al. Carotid intima\u2013media thickness and small dense low-density lipoprotein cholesterol increase after one year of treatment with direct-acting antivirals in patients with hepatitis C virus infection. Intern. Med. 58, 1209\u20131215. https:\/\/doi.org\/10.2169\/internalmedicine.1514-18 (2019).","journal-title":"Intern. Med."},{"key":"15827_CR30","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1161\/CIRCULATIONAHA.117.028595","volume":"137","author":"A O\u2019Neil","year":"2018","unstructured":"O\u2019Neil, A., Scovelle, A. J., Milner, A. J. & Kavanagh, A. Gender\/sex as a social determinant of cardiovascular risk. Circulation 137, 854\u2013864. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028595 (2018).","journal-title":"Circulation"},{"key":"15827_CR31","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.amjcard.2016.08.045","volume":"118","author":"O Perelshtein Brezinov","year":"2016","unstructured":"Perelshtein Brezinov, O. et al. Gender-related cardiovascular risk in healthy middle-aged adults. Am. J. Cardiol. 118, 1669\u20131673. https:\/\/doi.org\/10.1016\/j.amjcard.2016.08.045 (2016).","journal-title":"Am. J. Cardiol."},{"key":"15827_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2018.09.003","volume":"45","author":"C Martinez","year":"2020","unstructured":"Martinez, C. et al. Gender identity, hormone therapy, and cardiovascular disease risk. Curr. Probl. Cardiol. 45, 100396. https:\/\/doi.org\/10.1016\/j.cpcardiol.2018.09.003 (2020).","journal-title":"Curr. Probl. Cardiol."},{"key":"15827_CR33","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/j.jfma.2019.07.008","volume":"118","author":"HY Li","year":"2019","unstructured":"Li, H. Y. et al. Trends of mortality in diabetic patients in Taiwan: A nationwide survey in 2005\u20132014. J. Formos. Med. Assoc. 118, S83\u2013S89. https:\/\/doi.org\/10.1016\/j.jfma.2019.07.008 (2019).","journal-title":"J. Formos. Med. Assoc."},{"key":"15827_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3047","volume":"34","author":"A Nusca","year":"2018","unstructured":"Nusca, A. et al. Glycemic variability in the development of cardiovascular complications in diabetes. Diabetes Metab. Res. Rev. 34, e3047. https:\/\/doi.org\/10.1002\/dmrr.3047 (2018).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"15827_CR35","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1007\/s00125-019-4901-6","volume":"62","author":"MP Bancks","year":"2019","unstructured":"Bancks, M. P. et al. Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality. Diabetologia 62, 1366\u20131374. https:\/\/doi.org\/10.1007\/s00125-019-4901-6 (2019).","journal-title":"Diabetologia"},{"key":"15827_CR36","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2337\/dc19-0823","volume":"43","author":"S Li","year":"2020","unstructured":"Li, S. et al. Visit-to-visit HbA1c variability is associated with cardiovascular disease and microvascular complications in patients with newly diagnosed type 2 diabetes. Diabetes Care 43, 426\u2013432. https:\/\/doi.org\/10.2337\/dc19-0823 (2020).","journal-title":"Diabetes Care"},{"key":"15827_CR37","first-page":"157","volume":"104","author":"CC Lin","year":"2005","unstructured":"Lin, C. C., Lai, M. S., Syu, C. Y., Chang, S. C. & Tseng, F. Y. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J. Formos. Med. Assoc. 104, 157\u2013163 (2005).","journal-title":"J. Formos. Med. Assoc."},{"key":"15827_CR38","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1016\/j.jfma.2019.06.016","volume":"118","author":"YJ Sheen","year":"2019","unstructured":"Sheen, Y. J. et al. Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan. J. Formos. Med. Assoc. 118, S66\u2013S73. https:\/\/doi.org\/10.1016\/j.jfma.2019.06.016 (2019).","journal-title":"J. Formos. Med. Assoc."},{"key":"15827_CR39","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1464-5491.2010.03007.x","volume":"27","author":"CH Chang","year":"2010","unstructured":"Chang, C. H. et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999\u20132004: A national health insurance data set study. Diabet. Med. 27, 636\u2013643. https:\/\/doi.org\/10.1111\/j.1464-5491.2010.03007.x (2010).","journal-title":"Diabet. Med."},{"key":"15827_CR40","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo, R. A., Cherkin, D. C. & Ciol, M. A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J. Clin. Epidemiol. 45, 613\u2013619. https:\/\/doi.org\/10.1016\/0895-4356(92)90133-8 (1992).","journal-title":"J. Clin. Epidemiol."},{"key":"15827_CR41","first-page":"15","volume":"14","author":"BA Young","year":"2008","unstructured":"Young, B. A. et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am. J. Manag. Care 14, 15\u201323 (2008).","journal-title":"Am. J. Manag. Care"},{"key":"15827_CR42","unstructured":"National Health Research Institutes, Taiwan Society of Nephrology. Annual report on kidney disease in Taiwan (2019). https:\/\/www.tsn.org.tw\/enVersion\/TWRDS.aspx [Accessed November 14, 2021]."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15827-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15827-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15827-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:41:35Z","timestamp":1669358495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15827-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15827"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15827-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2022,7,9]]},"assertion":[{"value":"4 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11720"}}